Ind-Swift Laboratories Ltd reports Q2 FY27 consolidated revenue of ₹240.46 crore and net profit of ₹34.22 crore
- Revenue rose 25.6% sequentially and 51.6% year on year; net profit increased 38.6% sequentially and 328.3% year on year.
- Standalone revenue was ₹234.89 crore, with EBITDA of ₹42.33 crore and an 18.0% margin.
- Board approved unaudited standalone and consolidated results on 29 October; limited-review reports were unqualified. Exceptional items: ₹0.58 crore.